Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New endovascular prosthesis is promising for non-surgical treatment of TAAs

06.08.2002


Research study shows promising results for non-surgical treatment of life threatening condition



Rodney White, MD, Chief of Vascular Surgery and Associate Chair, Department of Surgery at Harbor-UCLA Medical Center and Principal Investigator at the Research & Education Institute at Harbor-UCLA Medical Center (REI) is shedding new light on endovascular treatment of thoracic aortic aneurysms (TAAs). A life threatening condition caused by a weakening of the vascular wall of the aorta in the chest, TAAs can lead to either sudden death or death in a matter of hours if the aorta ruptures.

In an REI clinical study, Dr. White and a team of cardiovascular surgeons, radiologists and scientists have successfully treated approximately 60 patients over the last three years with thoracic aortic aneurysms, aortic dissections and other cause of acute rupture. REI and the Harbor-UCLA Medical Center hold the distinction of being the only study site in the Los Angeles area to conduct this FDA-approved Investigational Device Exemption (IDE) research. Results on the first 25 patients in this study were published in the Journal of Vascular Surgery, May 2001. Dr. White and his team are a part of a nationwide referral network that has also implanted endovascular prostheses into approximately 600 patients diagnosed with abdominal aortic aneurysms, the 13th leading cause of death in the United States.


Dr. White, a graduate of the State University of New York Upstate Medical Center, believes that this research holds much promise.

"With the development of endovascular prostheses to treat abdominal aortic aneurysms in the mid 1990’s, a concomitant effort to adapt this technology to the treatment of thoracic aneurysms has demonstrated promising preliminary results with a decrease in both major morbidity and mortality being noted in many patients," he says.

The new technology also makes repair of thoracic aortic aneurysms and dissections available to patients who are not considered to be reasonable candidates for conventional surgical repair. "Although the experience is preliminary, the magnitude of the conventional surgical procedure and the decreased incidence of morbidity and mortality with endovascular repairs support further evaluation of this technology," he adds.



The Research & Education Institute at Harbor-UCLA Medical Center, located on the campus of Harbor-UCLA Medical Center near Torrance, California, is a leading independent, not-for-profit biomedical research institute with an international reputation for scientific discovery, the training of physician-scientists and the provision of community service programs. It is an affiliate of both the David Geffen School of Medicine at UCLA and the Harbor-UCLA Medical Center and has an annual budget of $58 million. The Institute traces its roots back to 1952, when researchers and physicians joined forces with the UCLA School of Medicine on the campus of what was then known as Harbor General Hospital to conduct a handful of research studies. Today, more than 1,000 research projects and clinical trials are being conducted at REI, advancing scientific understanding in order to improve medical outcomes and promote innovation in such areas as autoimmune disorders, cancer, cardiovascular disease, developmental disorders and other pediatric health problems, diabetes, infectious disease, inherited disorders, male contraception, vaccine evaluation and research, and various aspects of women’s health.


Barbara T. Kerr | EurekAlert!
Further information:
http://www.rei.edu/

More articles from Health and Medicine:

nachricht Researchers release the brakes on the immune system
18.10.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht Norovirus evades immune system by hiding out in rare gut cells
12.10.2017 | University of Pennsylvania School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

Im Focus: Shrinking the proton again!

Scientists from the Max Planck Institute of Quantum Optics, using high precision laser spectroscopy of atomic hydrogen, confirm the surprisingly small value of the proton radius determined from muonic hydrogen.

It was one of the breakthroughs of the year 2010: Laser spectroscopy of muonic hydrogen resulted in a value for the proton charge radius that was significantly...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

Climate Engineering Conference 2017 Opens in Berlin

10.10.2017 | Event News

 
Latest News

Osaka university researchers make the slipperiest surfaces adhesive

18.10.2017 | Materials Sciences

Space radiation won't stop NASA's human exploration

18.10.2017 | Physics and Astronomy

Los Alamos researchers and supercomputers help interpret the latest LIGO findings

18.10.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>